Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I spoke with Cliff Flowers Today

"From Mr. Flowers perspective, if we can get back to a good licensing revenue stream then we could look at consistent dividends from the portfolio. This could set PTSC apart from all OTC Securities which would be both a marketing tool and an SP appreciator."

Did Mr. Flowers mention "dividends" or was that your thoughts only? Announcement of a dividend would create excitement from outside investors, imho.

.

.

.

Share
New Message
Please login to post a reply